av/gufic-biosciences--big.svg

NSE:GUFICBIO

Gufic Biosciences Limited

  • Stock

INR

Last Close

326.60

15/05 04:09

Market Cap

34.80B

Beta: 0.79

Volume Today

7.02K

Avg: 85.49K

PE Ratio

39.21

PFCF: -

Dividend Yield

0.03%

Payout:0%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
230.56M
-
314.58M
36.45%
435.32M
38.38%
566.40M
30.11%
784.50M
38.51%
940.84M
19.93%
1.02B
8.14%
1.02B
0.06%
1.05B
3.13%
1.50B
42.41%
average payables
262.57M
-
406.65M
54.87%
510.78M
25.61%
461.80M
9.59%
571.43M
23.74%
761.77M
33.31%
932.14M
22.37%
1.11B
18.89%
1.27B
14.59%
1.36B
6.79%
average receivables
163.30M
-
11.65M
92.86%
16.64M
42.80%
411.23M
2,371.50%
899.24M
118.67%
1.17B
29.82%
1.41B
20.42%
1.54B
9.20%
1.77B
15.12%
2.00B
12.96%
book value per share
3.39
-
3.50
3.40%
4.39
25.31%
5.81
32.24%
6.88
18.44%
9.68
40.80%
9.89
2.13%
17.89
80.94%
27.76
55.17%
35.87
29.21%
capex per share
-0.51
-
-0.32
36.25%
-0.13
61.36%
-0.45
260.42%
-1.06
134.17%
-1.68
58.70%
-4.14
146.16%
-1.47
64.57%
-9.16
524.77%
-19.35
111.21%
capex to depreciation
-1.60
-
-0.65
59.16%
-0.26
60.69%
-0.95
270.55%
-1.92
101.73%
-2.82
46.93%
-4.80
70.63%
-0.87
81.86%
-5.18
494.64%
-8.42
62.46%
capex to operating cash flow
-0.36
-
-0.23
37.89%
0.22
199.82%
0.80
253.88%
1.70
113.56%
-2.51
247.85%
-0.88
65.06%
-0.16
81.82%
-0.85
432.78%
7.06
929.90%
capex to revenue
-0.03
-
-0.02
48.25%
-0.00
71.04%
-0.01
192.36%
-0.03
95.15%
-0.04
36.16%
-0.11
200.63%
-0.03
74.01%
-0.11
291.07%
-0.27
138.34%
cash per share
0.21
-
0.61
185.98%
0.55
9.92%
0.37
32.92%
-0.15
139.47%
-0.39
166.74%
-0.83
113.35%
1.36
262.96%
2.74
101.63%
4.81
75.67%
days of inventory on hand
141.28
-
162.06
14.71%
175.61
8.36%
186.75
6.34%
239.23
28.10%
189.27
20.88%
220.78
16.64%
133.68
39.45%
98.18
26.55%
201.80
105.54%
days payables outstanding
172.01
-
218.13
26.81%
183.86
15.71%
117.76
35.95%
189.96
61.31%
156.19
17.78%
219.61
40.61%
160.05
27.12%
119.75
25.18%
143.29
19.66%
days sales outstanding
2.61
-
3.50
34.07%
3.39
3.12%
117.68
3,374.78%
120.64
2.51%
139.44
15.58%
150.14
7.67%
119.65
20.31%
90.68
24.21%
108.70
19.87%
debt to assets
0.30
-
0.26
14.21%
0.28
8.96%
0.32
13.72%
0.34
5.61%
0.35
3.68%
0.34
3.41%
0.16
53.54%
0.12
21.32%
0.39
214.26%
debt to equity
1.27
-
1.21
4.98%
1.26
3.97%
1.26
0.47%
1.49
17.65%
1.30
12.80%
1.26
3.24%
0.35
71.74%
0.24
32.57%
0.96
301.60%
dividend yield
0.01
-
0.00
59.22%
0.00
69.24%
0.00
37.58%
0.00
41.66%
0.00
40.60%
0.00
70.13%
0.00
68.89%
0.00
16.71%
0.00
51.33%
earnings yield
0.11
-
0.04
60.24%
0.02
45.81%
0.02
2.72%
0.02
18.28%
0.03
92.59%
0.05
40.88%
0.04
19.13%
0.04
0.36%
0.04
11.07%
enterprise value
719.63M
-
1.27B
76.04%
3.59B
183.45%
5.68B
58.05%
9.58B
68.83%
7.21B
24.71%
5.80B
19.60%
11.65B
100.90%
24.67B
111.67%
21.13B
14.34%
enterprise value over ebitda
5.70
-
8.56
50.24%
17.76
107.54%
20.34
14.48%
23.41
15.13%
14.45
38.30%
11.45
20.76%
13.59
18.71%
16.74
23.14%
15.40
7.99%
ev to operating cash flow
6.62
-
11.36
71.50%
-83.17
832.26%
-129.07
55.18%
-197.50
53.02%
138.54
170.15%
12.69
90.84%
13.08
3.07%
23.62
80.50%
-79.47
436.51%
ev to sales
0.59
-
0.84
42.89%
1.78
112.45%
2.28
28.20%
3.18
39.83%
2.06
35.40%
1.62
21.17%
2.39
47.37%
3.17
32.49%
3.06
3.36%
free cash flow per share
0.90
-
1.12
24.78%
-0.68
161.20%
-1.02
49.32%
-1.68
64.83%
-1.01
39.86%
0.58
156.85%
7.72
1,242.12%
1.61
79.10%
-22.09
1,468.99%
free cash flow yield
0.17
-
0.09
49.11%
-0.02
118.83%
-0.02
6.79%
-0.01
3.44%
-0.01
15.42%
0.01
195.75%
0.07
460.88%
0.01
90.39%
-0.12
1,928.74%
graham net net
-8.99
-
-9.82
9.18%
-11.30
15.11%
-4.95
56.24%
-7.99
61.47%
-7.66
4.12%
-10.68
39.45%
-3.96
62.96%
-2.35
40.67%
-22.76
869.93%
graham number
6.48
-
6.51
0.40%
9.67
48.58%
13.88
43.55%
17.85
28.54%
24.78
38.86%
22.90
7.58%
42.86
87.12%
78.58
83.36%
81.45
3.65%
income quality
1.73
-
1.71
1.32%
-0.39
122.57%
-0.24
36.74%
-0.30
24.08%
0.24
178.38%
2.00
742.32%
2.01
0.72%
1.09
45.88%
-0.33
130.61%
intangibles to total assets
0.00
-
0.00
34.46%
0.00
44.16%
0.00
56.60%
0.00
653.23%
0.00
186.51%
0.00
19.29%
0.00
27.39%
0.00
3.09%
0.00
32.65%
interest coverage
1.48
-
1.37
7.56%
2.05
49.50%
2.80
37.01%
3.91
39.50%
4.23
8.14%
3.52
16.67%
5.90
67.47%
37.35
532.86%
13.98
62.58%
interest debt per share
4.82
-
4.82
0.12%
6.21
29.00%
8.15
31.14%
11.35
39.28%
13.84
21.99%
13.65
1.35%
7.56
44.62%
7.00
7.40%
35.31
404.38%
inventory turnover
2.58
-
2.25
12.83%
2.08
7.72%
1.95
5.96%
1.53
21.94%
1.93
26.39%
1.65
14.27%
2.73
65.16%
3.72
36.15%
1.81
51.35%
invested capital
1.27
-
1.21
4.98%
1.26
3.97%
1.26
0.47%
1.49
17.65%
1.30
12.80%
1.26
3.24%
0.35
71.74%
0.24
32.57%
0.96
301.60%
market cap
402.22M
-
986.21M
145.19%
3.21B
225.10%
5.14B
60.19%
8.82B
71.77%
6.27B
28.89%
4.64B
26.05%
11.10B
139.29%
24.14B
117.47%
18.07B
25.13%
net current asset value
-156.33M
-
-84.40M
46.01%
14.09M
116.69%
112.49M
698.59%
144.78M
28.71%
283.22M
95.61%
30.94M
89.08%
419.58M
1,256.17%
684.70M
63.19%
-492.43M
171.92%
net debt to ebitda
2.51
-
1.90
24.54%
1.90
0.38%
1.93
1.54%
1.86
3.93%
1.88
1.53%
2.29
21.65%
0.65
71.86%
0.36
44.51%
2.23
521.89%
net income per share
0.55
-
0.54
2.51%
0.95
76.18%
1.48
55.83%
2.06
39.51%
2.82
36.94%
2.36
16.37%
4.56
93.52%
9.89
116.68%
8.22
16.85%
operating cash flow per share
1.40
-
1.44
2.65%
-0.56
138.71%
-0.57
1.85%
-0.62
9.65%
0.67
207.33%
4.71
604.47%
9.19
94.91%
10.77
17.27%
-2.74
125.45%
payables turnover
2.12
-
1.67
21.14%
1.99
18.64%
3.10
56.13%
1.92
38.01%
2.34
21.62%
1.66
28.88%
2.28
37.22%
3.05
33.66%
2.55
16.43%
receivables turnover
139.98
-
104.40
25.41%
107.77
3.23%
3.10
97.12%
3.03
2.45%
2.62
13.48%
2.43
7.13%
3.05
25.48%
4.03
31.94%
3.36
16.58%
research and ddevelopement to revenue
0.00
-
0.01
82.99%
0.02
186.53%
0.01
66.29%
0.01
5.58%
0.00
23.04%
0.01
32.07%
return on tangible assets
0.04
-
0.03
14.88%
0.05
47.32%
0.06
33.37%
0.07
5.78%
0.08
15.75%
0.06
18.23%
0.11
75.76%
0.18
62.93%
0.09
49.67%
revenue per share
15.90
-
19.59
23.20%
26.14
33.42%
32.23
23.28%
38.67
19.99%
45.07
16.55%
36.90
18.12%
50.31
36.32%
80.37
59.76%
71.22
11.38%
roe
0.16
-
0.15
5.71%
0.22
40.59%
0.25
17.84%
0.30
17.79%
0.29
2.74%
0.24
18.11%
0.26
6.95%
0.36
39.64%
0.23
35.65%
roic
0.07
-
0.06
1.83%
0.09
42.88%
0.11
17.43%
0.14
27.39%
0.15
9.33%
0.14
6.29%
0.22
56.29%
0.29
32.48%
0.12
58.34%
sales general and administrative to revenue
0.02
-
0.03
18.34%
0.03
15.70%
0.03
8.60%
0.02
25.31%
0.02
3.88%
0.02
12.50%
0.02
11.59%
0.02
3.00%
shareholders equity per share
3.39
-
3.50
3.40%
4.39
25.31%
5.81
32.24%
6.88
18.44%
9.68
40.80%
9.89
2.13%
17.89
80.94%
27.76
55.17%
35.87
29.21%
stock based compensation to revenue
tangible asset value
261.66M
-
270.68M
3.45%
339.38M
25.38%
448.96M
32.29%
534.08M
18.96%
749.82M
40.39%
952.97M
27.09%
1.73B
81.53%
2.69B
55.21%
3.47B
29.28%
tangible book value per share
3.38
-
3.50
3.45%
4.39
25.38%
5.80
32.29%
6.86
18.23%
9.63
40.39%
9.83
2.03%
17.84
81.53%
27.70
55.21%
35.87
29.51%
working capital
89.94M
-
81.39M
9.51%
159.73M
96.26%
288.87M
80.85%
297.79M
3.09%
461.70M
55.04%
389.13M
15.72%
969.20M
149.07%
1.34B
38.02%
1.76B
31.49%

All numbers in INR (except ratios and percentages)